ID

20216

Beschrijving

A Study of 1018 Immunostimulatory Sequence (ISS) Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00403052

Link

https://clinicaltrials.gov/show/NCT00403052

Trefwoorden

Versies (1)
  1. 14-02-17 14-02-17 -
Geüploaded op

14 februari 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Colorectal Neoplasms NCT00403052

Engels

Eligibility Colorectal Neoplasms NCT00403052

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
signed, written, informed consent must be obtained from the patient or their legal representative before any study-specific procedures are performed
Beschrijving

Informed Consent | Informed Consent Patient Representatives

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0030701
confirmed diagnosis of adenocarcinoma of the colon or rectum not amenable to curative surgery
Beschrijving

Adenocarcinoma of colon Amenable Curative Surgery | Adenocarcinoma of rectum Amenable Curative Surgery

Datatype

boolean

Alias
UMLS CUI [1,1]
C0338106
UMLS CUI [1,2]
C3900053
UMLS CUI [1,3]
C1511562
UMLS CUI [2,1]
C0149978
UMLS CUI [2,2]
C3900053
UMLS CUI [2,3]
C1511562
one or more prior systemic therapy regimens for metastatic cancer which must have included a fluoropyrimidine (5-fluorouracil (fu) by infusion or capecitabine), oxaliplatin or irinotecan with or without bevacizumab
Beschrijving

systemic therapy Quantity Neoplasm Metastasis | fluoropyrimidine | Fluorouracil Infusion | capecitabine | oxaliplatin | irinotecan | bevacizumab

Datatype

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0027627
UMLS CUI [2]
C0596581
UMLS CUI [3,1]
C0016360
UMLS CUI [3,2]
C0574032
UMLS CUI [4]
C0671970
UMLS CUI [5]
C0069717
UMLS CUI [6]
C0123931
UMLS CUI [7]
C0796392
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinically significant obstructive symptoms, intestinal bleeding, or chronic or recent acute gastrointestinal disorder with diarrhea as a major symptom
Beschrijving

Symptoms Obstructive | Intestinal hemorrhage | Gastrointestinal Diseases chronic | Gastrointestinal Diseases | Diarrhea Symptoms Major

Datatype

boolean

Alias
UMLS CUI [1,1]
C1457887
UMLS CUI [1,2]
C0549186
UMLS CUI [2]
C0267373
UMLS CUI [3,1]
C0017178
UMLS CUI [3,2]
C0205191
UMLS CUI [4]
C0017178
UMLS CUI [5,1]
C0011991
UMLS CUI [5,2]
C1457887
UMLS CUI [5,3]
C0205164
history of unstable or deteriorating cardiovascular or cerebrovascular disease within 3 months before the first dose of protocol therapy
Beschrijving

Cardiovascular Disease Unstable | Cardiovascular Disease Worsening | Cerebrovascular Disorder Unstable | Cerebrovascular Disorder Worsening

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0443343
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C0332271
UMLS CUI [3,1]
C0007820
UMLS CUI [3,2]
C0443343
UMLS CUI [4,1]
C0007820
UMLS CUI [4,2]
C0332271
clinical evidence of brain metastases or central nervous system disease
Beschrijving

Metastatic malignant neoplasm to brain Evidence Clinical | CNS disorder Evidence Clinical

Datatype

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C3887511
UMLS CUI [1,3]
C0205210
UMLS CUI [2,1]
C0007682
UMLS CUI [2,2]
C3887511
UMLS CUI [2,3]
C0205210
pregnant or lactating women
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
serious medical or psychiatric illness
Beschrijving

Disease Serious | Serious mental illness

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
UMLS CUI [2]
C3841614
malignancy other than colorectal carcinoma within the past 2 years, except curatively treated, superficial skin cancer or carcinoma in situ of the cervix
Beschrijving

Malignant Neoplasms | Colorectal Carcinoma | Skin carcinoma Superficial Curative treatment | Carcinoma in situ of uterine cervix Curative treatment

Datatype

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0009402
UMLS CUI [3,1]
C0699893
UMLS CUI [3,2]
C0205124
UMLS CUI [3,3]
C1273390
UMLS CUI [4,1]
C0851140
UMLS CUI [4,2]
C1273390
patients who have been on any experimental study or anti-tumor therapy, received radiotherapy, or had prior surgery (except venous access device placement) within 28 days before the first dose of protocol therapy
Beschrijving

Research study participation | cancer treatment | Therapeutic radiology procedure | Operative Surgical Procedures | Venous access device implantation

Datatype

boolean

Alias
UMLS CUI [1,1]
C0681814
UMLS CUI [1,2]
C0679823
UMLS CUI [2]
C0920425
UMLS CUI [3]
C1522449
UMLS CUI [4]
C0543467
UMLS CUI [5]
C1700941
Terug naar het begin van de pagina

Similar models

Eligibility Colorectal Neoplasms NCT00403052

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent | Informed Consent Patient Representatives
Item
signed, written, informed consent must be obtained from the patient or their legal representative before any study-specific procedures are performed
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Adenocarcinoma of colon Amenable Curative Surgery | Adenocarcinoma of rectum Amenable Curative Surgery
Item
confirmed diagnosis of adenocarcinoma of the colon or rectum not amenable to curative surgery
boolean
C0338106 (UMLS CUI [1,1])
C3900053 (UMLS CUI [1,2])
C1511562 (UMLS CUI [1,3])
C0149978 (UMLS CUI [2,1])
C3900053 (UMLS CUI [2,2])
C1511562 (UMLS CUI [2,3])
systemic therapy Quantity Neoplasm Metastasis | fluoropyrimidine | Fluorouracil Infusion | capecitabine | oxaliplatin | irinotecan | bevacizumab
Item
one or more prior systemic therapy regimens for metastatic cancer which must have included a fluoropyrimidine (5-fluorouracil (fu) by infusion or capecitabine), oxaliplatin or irinotecan with or without bevacizumab
boolean
C1515119 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0596581 (UMLS CUI [2])
C0016360 (UMLS CUI [3,1])
C0574032 (UMLS CUI [3,2])
C0671970 (UMLS CUI [4])
C0069717 (UMLS CUI [5])
C0123931 (UMLS CUI [6])
C0796392 (UMLS CUI [7])
Item Group
C0680251 (UMLS CUI)
Symptoms Obstructive | Intestinal hemorrhage | Gastrointestinal Diseases chronic | Gastrointestinal Diseases | Diarrhea Symptoms Major
Item
clinically significant obstructive symptoms, intestinal bleeding, or chronic or recent acute gastrointestinal disorder with diarrhea as a major symptom
boolean
C1457887 (UMLS CUI [1,1])
C0549186 (UMLS CUI [1,2])
C0267373 (UMLS CUI [2])
C0017178 (UMLS CUI [3,1])
C0205191 (UMLS CUI [3,2])
C0017178 (UMLS CUI [4])
C0011991 (UMLS CUI [5,1])
C1457887 (UMLS CUI [5,2])
C0205164 (UMLS CUI [5,3])
Cardiovascular Disease Unstable | Cardiovascular Disease Worsening | Cerebrovascular Disorder Unstable | Cerebrovascular Disorder Worsening
Item
history of unstable or deteriorating cardiovascular or cerebrovascular disease within 3 months before the first dose of protocol therapy
boolean
C0007222 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2,1])
C0332271 (UMLS CUI [2,2])
C0007820 (UMLS CUI [3,1])
C0443343 (UMLS CUI [3,2])
C0007820 (UMLS CUI [4,1])
C0332271 (UMLS CUI [4,2])
Metastatic malignant neoplasm to brain Evidence Clinical | CNS disorder Evidence Clinical
Item
clinical evidence of brain metastases or central nervous system disease
boolean
C0220650 (UMLS CUI [1,1])
C3887511 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C0007682 (UMLS CUI [2,1])
C3887511 (UMLS CUI [2,2])
C0205210 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Disease Serious | Serious mental illness
Item
serious medical or psychiatric illness
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C3841614 (UMLS CUI [2])
Malignant Neoplasms | Colorectal Carcinoma | Skin carcinoma Superficial Curative treatment | Carcinoma in situ of uterine cervix Curative treatment
Item
malignancy other than colorectal carcinoma within the past 2 years, except curatively treated, superficial skin cancer or carcinoma in situ of the cervix
boolean
C0006826 (UMLS CUI [1])
C0009402 (UMLS CUI [2])
C0699893 (UMLS CUI [3,1])
C0205124 (UMLS CUI [3,2])
C1273390 (UMLS CUI [3,3])
C0851140 (UMLS CUI [4,1])
C1273390 (UMLS CUI [4,2])
Research study participation | cancer treatment | Therapeutic radiology procedure | Operative Surgical Procedures | Venous access device implantation
Item
patients who have been on any experimental study or anti-tumor therapy, received radiotherapy, or had prior surgery (except venous access device placement) within 28 days before the first dose of protocol therapy
boolean
C0681814 (UMLS CUI [1,1])
C0679823 (UMLS CUI [1,2])
C0920425 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0543467 (UMLS CUI [4])
C1700941 (UMLS CUI [5])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial